BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30171718)

  • 21. Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets.
    Mitsche MA; Hobbs HH; Cohen JC
    J Biol Chem; 2018 May; 293(18):6958-6968. PubMed ID: 29555681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethanol-triggered Lipophagy Requires SQSTM1 in AML12 Hepatic Cells.
    Wang L; Zhou J; Yan S; Lei G; Lee CH; Yin XM
    Sci Rep; 2017 Sep; 7(1):12307. PubMed ID: 28951592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury.
    Zheng YY; Wang M; Shu XB; Zheng PY; Ji G
    World J Gastroenterol; 2018 Mar; 24(9):992-1003. PubMed ID: 29531463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
    Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipophagy-derived fatty acids undergo extracellular efflux via lysosomal exocytosis.
    Cui W; Sathyanarayan A; Lopresti M; Aghajan M; Chen C; Mashek DG
    Autophagy; 2021 Mar; 17(3):690-705. PubMed ID: 32070194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct lysosome-based autophagy of lipid droplets in hepatocytes.
    Schulze RJ; Krueger EW; Weller SG; Johnson KM; Casey CA; Schott MB; McNiven MA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32443-32452. PubMed ID: 33288726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
    Mastoridou EM; Goussia AC; Kanavaros P; Charchanti AV
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variants in the autophagy-related gene IRGM confer susceptibility to non-alcoholic fatty liver disease by modulating lipophagy.
    Lin YC; Chang PF; Lin HF; Liu K; Chang MH; Ni YH
    J Hepatol; 2016 Dec; 65(6):1209-1216. PubMed ID: 27417217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice.
    Kabbani M; Michailidis E; Steensels S; Fulmer CG; Luna JM; Le Pen J; Tardelli M; Razooky B; Ricardo-Lax I; Zou C; Zeck B; Stenzel AF; Quirk C; Foquet L; Ashbrook AW; Schneider WM; Belkaya S; Lalazar G; Liang Y; Pittman M; Devisscher L; Suemizu H; Theise ND; Chiriboga L; Cohen DE; Copenhaver R; Grompe M; Meuleman P; Ersoy BA; Rice CM; de Jong YP
    Cell Rep; 2022 Sep; 40(11):111321. PubMed ID: 36103835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphenol A inhibits autophagosome-lysosome fusion and lipid droplet degradation.
    Song D; Chen Y; Wang B; Li D; Xu C; Huang H; Huang S; Liu R
    Ecotoxicol Environ Saf; 2019 Nov; 183():109492. PubMed ID: 31421534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
    Scorletti E; West AL; Bhatia L; Hoile SP; McCormick KG; Burdge GC; Lillycrop KA; Clough GF; Calder PC; Byrne CD
    J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis.
    BasuRay S; Wang Y; Smagris E; Cohen JC; Hobbs HH
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9521-9526. PubMed ID: 31019090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.
    Schwerbel K; Kamitz A; Krahmer N; Hallahan N; Jähnert M; Gottmann P; Lebek S; Schallschmidt T; Arends D; Schumacher F; Kleuser B; Haltenhof T; Heyd F; Gancheva S; Broman KW; Roden M; Joost HG; Chadt A; Al-Hasani H; Vogel H; Jonas W; Schürmann A
    J Hepatol; 2020 Oct; 73(4):771-782. PubMed ID: 32376415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis.
    Banini BA; Kumar DP; Cazanave S; Seneshaw M; Mirshahi F; Santhekadur PK; Wang L; Guan HP; Oseini AM; Alonso C; Bedossa P; Koduru SV; Min HK; Sanyal AJ
    Hepatology; 2021 Apr; 73(4):1290-1306. PubMed ID: 33131062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way.
    Marmugi A; Lukowicz C; Lasserre F; Montagner A; Polizzi A; Ducheix S; Goron A; Gamet-Payrastre L; Gerbal-Chaloin S; Pascussi JM; Moldes M; Pineau T; Guillou H; Mselli-Lakhal L
    Toxicol Appl Pharmacol; 2016 Jul; 303():90-100. PubMed ID: 27180240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated Action of Autophagy and Adipose Tissue Triglyceride Lipase Ameliorates Diet-Induced Hepatic Steatosis in Liver-Specific PLIN2 Knockout Mice.
    Griffin JD; Bejarano E; Wang XD; Greenberg AS
    Cells; 2021 Apr; 10(5):. PubMed ID: 33923083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective Lipid Droplet-Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115.
    Larsen LE; van den Boogert MAW; Rios-Ocampo WA; Jansen JC; Conlon D; Chong PLE; Levels JHM; Eilers RE; Sachdev VV; Zelcer N; Raabe T; He M; Hand NJ; Drenth JPH; Rader DJ; Stroes ESG; Lefeber DJ; Jonker JW; Holleboom AG
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):583-597. PubMed ID: 34626841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
    Stättermayer AF; Traussnigg S; Aigner E; Kienbacher C; Huber-Schönauer U; Steindl-Munda P; Stadlmayr A; Wrba F; Trauner M; Datz C; Ferenci P
    J Trace Elem Med Biol; 2017 Jan; 39():100-107. PubMed ID: 27908400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
    Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
    Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Notch1 inhibits the mechanistic role of STING signaling to regulate hepatocyte lipophagy in nonalcoholic steatohepatitis].
    Yang T; Zhao JY; Wang X; Fang ZG; Jiang LF; Li J
    Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):827-834. PubMed ID: 37723064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.